STE · 8-K · 20260805PR053412
Revenue Performance and Mix
STERIS plc · 2026-08-05 · Importance 42 · Surprise 14 · From source text
Fiscal 2027 first-quarter revenue increased 7.3% year over year to $1,492.7 million from $1,391.1 million, while constant-currency organic revenue growth was 6.2%. Recurring revenue increased to $1,229.6 million from $1,135.6 million, comprising $755.5 million of service revenue and $474.0 million of consumables revenue, while capital equipment revenue rose to $263.2 million from $255.5 million. Healthcare revenue increased 7.6% to $1,048.3 million, AST revenue increased 5.8% to $297.6 million, and Life Sciences revenue increased 8.6% to $146.7 million. United States revenue increased to $1,090.6 million and represented 73% of total revenue, while international revenue increased to $373.2 million and represented 25%.
Key facts
- Total recurring revenues in Q1 FY2027 were $1,229.6 million (consumables $474.0 million and service $755.5 million) and capital equipment revenue was $263.2 million. source
- Total revenue for the first quarter of fiscal 2027 increased 7% to $1.5 billion compared with $1.4 billion in the first quarter of fiscal 2026. source
- Healthcare revenue as reported grew 8% in the first quarter to $1.05 billion compared with $974.7 million in the first quarter of fiscal 2026. source
- Applied Sterilization Technologies (AST) first quarter revenue increased 6% as reported to $297.6 million compared with $281.2 million in the same period last year. source
- As reported, net income for the first quarter was $200.1 million, or $2.04 per diluted share, compared with net income of $177.4 million, or $1.79 per diluted share, in the first quarter of fiscal 2026. source
- Adjusted net income for the first quarter of fiscal 2027 was $253.4 million, or $2.59 per diluted share, compared with $231.2 million or $2.34 per diluted share in the prior-year first quarter. source
- As reported, U.S. GAAP revenues for the three months ended June 30, 2026 were $1,492.7 million compared with $1,391.1 million for 2025. source
- United States revenues for Q1 FY2027 were $1,090.6 million, representing 73% of total revenues, while International revenues were $373.2 million, representing 25% of total revenues. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +6.8% | As reported, U.S. GAAP revenues for the three months ended June 30, 2026 were $1,492.7 million compared with $1,391.1 million for 2025. |
| revenue | positive | realized | +5.0% | Healthcare revenue as reported grew 8% in the first quarter to $1.05 billion compared with $974.7 million in the first quarter of fiscal… |
| net_income | positive | realized | +1.5% | As reported, net income for the first quarter was $200.1 million, or $2.04 per diluted share, compared with net income of $177.4 million,… |
| net_income | positive | realized | +1.5% | Adjusted net income for the first quarter of fiscal 2027 was $253.4 million, or $2.59 per diluted share, compared with $231.2 million or… |
| revenue | positive | realized | +1.1% | Applied Sterilization Technologies (AST) first quarter revenue increased 6% as reported to $297.6 million compared with $281.2 million in… |